DiscoverGlobal HIV Vaccine Enterprise AIDS Vaccine 2012 ConferenceSymposia 06: Preclinical Studies and Vaccine Platforms: E-DNA IM or ID Delivery Prime Enhances Antibody and T Cell Responses Following Recombinant gp120 Env Boost
Symposia 06:  Preclinical Studies and Vaccine Platforms: E-DNA IM or ID Delivery Prime Enhances Antibody and T Cell Responses Following Recombinant gp120 Env Boost

Symposia 06: Preclinical Studies and Vaccine Platforms: E-DNA IM or ID Delivery Prime Enhances Antibody and T Cell Responses Following Recombinant gp120 Env Boost

Update: 2020-09-15
Share

Description

Symposia 06: Preclinical Studies and Vaccine Platforms: E-DNA IM or ID Delivery Prime Enhances Antibody and T Cell Responses Following Recombinant gp120 Env Boost by David B. Weiner University of Pennsylvania,Pathology and Laboratory Medicine, Philadelphia, PA United States of America
Comments 
In Channel
Closing Session

Closing Session

2020-09-15--:--

loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Symposia 06:  Preclinical Studies and Vaccine Platforms: E-DNA IM or ID Delivery Prime Enhances Antibody and T Cell Responses Following Recombinant gp120 Env Boost

Symposia 06: Preclinical Studies and Vaccine Platforms: E-DNA IM or ID Delivery Prime Enhances Antibody and T Cell Responses Following Recombinant gp120 Env Boost

Global HIV Vaccine Enterprise